8:00 am – Registration and Breakfast
9:00 am – Introductory Remarks
Emilio Ragosa
9:15 am – Diplomacy, Disruption, and Direction: A Fireside Chat on US Global Engagement
Senator Richard Burr, Ambassador Marc Grossman (The Cohen Group), and Emilio Ragosa
9:45 am – Legal Strategy for Life Sciences in a Tariff-Era Economy: Incentives, Trade, and Strategic Site Selection
Stephanie Yarbrough and Ting Xiao
10:15 am – Bridging Science and Strategy: Collaborations that Deliver
Tracy Dowling (AskBio), Jared Freedberg (Arvinas), Sonia de Kondserovsky, Lauren Murdza, and Aurely Vervondel (argenx)
10:45 am – Coffee Break
11:15 am – Transforming Life Sciences with AI: Real-World Use Cases and Emerging Frontiers
Larissa Bifano, Denise Butler (Johnson & Johnson), Ittai Dayan (Rhino Federated Computing), Kristina Kitko (Eli Lilly), Allen Waxman, and Camille Whicker (Microsoft)
12:00 pm – Global M&A Life Sciences Outlook and Adapting to the Current Market Dynamics
David Clark, Emilio Ragosa, and Victoria Rhodes
12:30 pm – Lunch and Networking
1:30 pm – The Price Is Right, or Is It? What’s Next in Drug Pricing Policy
Kirsten Axelsen, Ellen Lukens (Health Transformation Strategies), and Preeya Pinto
2:00 pm – FDA at the Crossroads: How Evolving Regulatory Priorities Are Affecting Global Life Sciences Companies
Kenita Barrow (Otsuka America Pharmaceutical, Inc.), Sarah Karlgaard (Fujifilm Holdings American Corporation), and Vernessa Pollard
2:30 pm – Navigating Global Product Liability: Legal Trends and the EU’s New Rules
Cara Edwards, Mary Gately, Jeremy Sher, and Michael W. King (Jazz Pharmaceuticals)
3:00 pm – Fun snack and Coffee break
3:30 pm – Managing Business Views of LOE (Loss of Exclusivity) in Real Time: Patent Expiration and Global IP Strategy
Jenny Alonso (Neurelis), Nicole Endejann, Ray Miller, Aoife Murphy, Nick Tyacke, and Dr. Irfan Qureshi (Biohaven)
4:15 pm – Compliance and Investigations: Navigating an Uncertain Enforcement Environment
Eric Christofferson, Lisa Kutlin (Pfizer), Lisa LeCointe-Cephas (Johnson & Johnson Innovative Medicine), Dana McMahon (Stryker), and Jeff Scott
5:00 pm – The EU Life Sciences Landscape: Trends, Risks, and Opportunities
Marco de Morpurgo and Stefano Marino
5:30 pm – Closing Remarks
Sang Kim
5:30 pm – Cocktail Reception
.jpg?h=975&iar=0&w=2560)
